Lecture Notes

**Lecture Coverage:**
- Schizophrenia & Antipsychotics
- Parkinson's Disease & L-DOPA
- Depression & Antidepressants

---
#### **Schizophrenia & Antipsychotics**
- Treats positive symptoms of Schizophrenia (Hallucinations & Delusion)
	- ∵ Hyperactivity specifically in the <abbr Title="from midbrain to Nucleus Accumbens">Mesolimbic pathway</abbr> in charge of reward & addiction

**Mechanism of Action**
- D<sub>2</sub> Receptor Antagonism → ↓ <abbr Title="esp. Mesolimbic pathway">Central</abbr> Dopaminergic Transmission

**Types of Antipsychotics**

|             Type             |                Examples                | Mechanism                                                                         | Characteristics                               |
| :--------------------------: | :------------------------------------: | --------------------------------------------------------------------------------- | --------------------------------------------- |
| 1st Generation<br>(Typical)  |     Haloperidol<br>Chlorpromazine      | Strong D<sub>2</sub> Antagonism → Positive Symptom                                | ↑ EPS Risk<br>                                |
| 2nd Generation<br>(Atypical) | Olanzapine<br>Clozapine<br>Risperidone | Weaker D<sub>2</sub> Antagonism<br>5-HT<sub>2</sub> Antagonism → Negative Symptom | ↓ EPS Risk<br>↑ Lipid Metabolism Side Effects |

**Side Effects**
- Nigrostriatal Pathway DA Blockade → <abbr Title="Extrapyramidal Symptoms">EPS</abbr>:
	- Acute Dystonia: Sudden Muscle Spasms
	- Tardive Dyskinesia: Abnormal Facial & Trunk Movements
	- Akathisia: Motor Restlessness
	- Pseudo-Parkinsonism: Tremor & Rigidity
- Tuberoinfundibular Pathway DA Blockade
	- ↑ [[Lecture 3.1 (Endocrine System) - Endocrine Control & Actions|Prolactin]] Secretion
- ↓ Drug Specificity → Blockade of Other Receptors
	- α<sub>1</sub> Blockade: Postural Hypotension
	- H<sub>1</sub> Blockade: Sedation
	- M Blockade: Constipation & Urinary Retention


#### **Parkinson's Disease & L-DOPA**
- Parkinson's Disease: 
	- Progressive Dopaminergic Loss in Substantia Nigra → ↓ Nigrostriatal Pathway DA Transmission → Motor symptoms
- L-DOPA:
	- Dopamine precursor that can pass BBB → Converted by <abbr Title="DOPA decarboxylase">DDC</abbr> in brain
	- Enhance remaining DA transmission in Nigrostriatal Pathway

**L-DOPA Enhancing Drugs**
- Peripheral DDC Inhibitors (Carbidopa, Benserazide)
	- Inhibits <abbr Title="e.g. Gut, Liver">Peripheral</abbr> DDC → ↑ L-DOPA reaching the brain
	- Does not Cross BBB
- <abbr Title="Monoamine Oxidase-B">MAO-B</abbr> Inhibitors (Sele<font color=yellow>giline</font>, Rasa<font color=yellow>giline</abbr>)
	- Selective & Irreversible MAO-B Inhibition → ↓ Neuronal DA Catabolism
- <abbr Title="Catachol-O-Methyltransferase">COMT</abbr> Inhibitors (Enta<font color=yellow>capone</font>, Tol<font color=yellow>capone</font>)
	- COMT Inhibition → ↓ L-DOPA & DA Catabolism
		- Entacapone: Acts Peripherally
		- Tolcapone: Acts <abbr Title="Crosses BBB">Centrally</abbr> & Peripherally


#### **Depression & Antidepressants**
**Depression**
- Anhedonia, Low Energy & Mood for >2 weeks

**Monoamine Theory**
- Depressive Symptoms are due to Functional Deficiency in CNS <abbr Title="e.g. NA, 5-HT">Monoamine</abbr> Transmission
	- → Current Antidepressants mostly works by ↑ Synaptic <abbr Title="e.g. NA, 5-HT">Monoamine</abbr> Transmission
- Contradiction: Time lag & Limited responsiveness in current antidepressants despite antidepressants should have immediate effects
	- ∵ 5-HT Reuptake Inhibition also activates Inhibitory 


**Major Classes of Antidepressants**
- <abbr Title="Neuronal Norepinephrine Transporter">NET</abbr>(NA Reuptake) / <abbr Title="Neuronal Serotonin Transporter">SERT</abbr>(5-HT Reuptake) / <abbr Title="Neuronal Dopamine Transporter">DAT</abbr>(DA) Inhibitors → ↑ Synaptic Availability

| Type                                                                      | Transporters Inhibited | Advantages                                      | Disadvantages                                                             |
| ------------------------------------------------------------------------- | ---------------------- | ----------------------------------------------- | ------------------------------------------------------------------------- |
| <abbr Title="Selective Serotonin Reuptake Inhibitors">SSRI</abbr>         | SERT                   | Safer in Overdose<br>Less Side Effects than TCA | GI Upset<br>Sexual Dysfunction<br>↑ Suicidal Thoughts in Youth            |
| <abbr Title="Classical Tricyclic Antidepressants">TCA</abbr>              | SERT / NET             | Effective<br>Analgesic                          | ↓ Selectivity → Side Effects<br>- Cardiac Toxicity<br>- Fatal in Overdose |
| <abbr Title="Dual Serotonin/Noradrenaline Reuptake Inhibitor">SNRI</abbr> | SERT / NET             | Dual Action → ↑ Efficacy<br>for Neurologic Pain | SSRI-like Side Effects<br>                                                |
| <abbr Title="Noradrenaline/Dopamine Reuptake Inhibitor">NDRI</abbr>       | DAT / NET              | ↓ Sexual Dysfunction<br>for Smoking Cessation   | Agitation & Insomnia                                                      |
